(1- N- biotinyl- (13- N- succinimidyl- ((E,E- farnesyl)- cysteinyl)- valinyl- isoleucinyl- alanine))- 4,7,10- trioxatridecanediamine

structure in first source

Also Known As:

(1-N-biotinyl-(13-N-succinimidyl-(S-(E,E-farnesyl)-L-cysteinyl)-L-valinyl-L-isoleucinyl-L-alanine))-4,7,10-trioxatridecanediamine; Ca1a2X peptide

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)